These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8137114)

  • 1. Ten-year follow-up of 50 patients with bulimia nervosa.
    Collings S; King M
    Br J Psychiatry; 1994 Jan; 164(1):80-7. PubMed ID: 8137114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social adjustment over 10 years following diagnosis with bulimia nervosa.
    Keel PK; Mitchell JE; Miller KB; Davis TL; Crow SJ
    Int J Eat Disord; 2000 Jan; 27(1):21-8. PubMed ID: 10590445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and predictors of recovery in anorexia nervosa and bulimia nervosa.
    Herzog DB; Sacks NR; Keller MB; Lavori PW; von Ranson KB; Gray HM
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):835-42. PubMed ID: 8340307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bulimia nervosa: a 5-year follow-up study.
    Johnson-Sabine E; Reiss D; Dayson D
    Psychol Med; 1992 Nov; 22(4):951-9. PubMed ID: 1488490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bulimia nervosa: 5-year social outcome and relationship to eating pathology.
    Reiss D; Johnson-Sabine E
    Int J Eat Disord; 1995 Sep; 18(2):127-33. PubMed ID: 7581414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial.
    Carruba MO; Cuzzolaro M; Riva L; Bosello O; Liberti S; Castra R; Dalle Grave R; Santonastaso P; Garosi V; Nisoli E
    Int Clin Psychopharmacol; 2001 Jan; 16(1):27-32. PubMed ID: 11195257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
    Romano SJ; Halmi KA; Sarkar NP; Koke SC; Lee JS
    Am J Psychiatry; 2002 Jan; 159(1):96-102. PubMed ID: 11772696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of prior substance abuse on treatment outcome for bulimia nervosa.
    Strasser TJ; Pike KM; Walsh BT
    Addict Behav; 1992; 17(4):387-95. PubMed ID: 1502972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and clinical course in inpatient bulimic women: a 2- to 9-year follow-up study.
    Fallon BA; Walsh BT; Sadik C; Saoud JB; Lukasik V
    J Clin Psychiatry; 1991 Jun; 52(6):272-8. PubMed ID: 2055901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of bulimia among secondary school students in Casablanca].
    Ghazal N; Agoub M; Moussaoui D; Battas O
    Encephale; 2001; 27(4):338-42. PubMed ID: 11686055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postremission predictors of relapse in women with eating disorders.
    Keel PK; Dorer DJ; Franko DL; Jackson SC; Herzog DB
    Am J Psychiatry; 2005 Dec; 162(12):2263-8. PubMed ID: 16330589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate and prediction of relapse in bulimia nervosa.
    Olmsted MP; Kaplan AS; Rockert W
    Am J Psychiatry; 1994 May; 151(5):738-43. PubMed ID: 8166317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective 10-year follow-up in adolescent anorexia nervosa--course, outcome, psychiatric comorbidity, and psychosocial adaptation.
    Herpertz-Dahlmann B; Müller B; Herpertz S; Heussen N; Hebebrand J; Remschmidt H
    J Child Psychol Psychiatry; 2001 Jul; 42(5):603-12. PubMed ID: 11464965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome in bulimia nervosa.
    Keel PK; Mitchell JE
    Am J Psychiatry; 1997 Mar; 154(3):313-21. PubMed ID: 9054777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group.
    Goldstein DJ; Wilson MG; Thompson VL; Potvin JH; Rampey AH
    Br J Psychiatry; 1995 May; 166(5):660-6. PubMed ID: 7620754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictors of symptomatic improvement in eating disorders. Preliminary analysis].
    Cygankiewicz P; Solecka D; Pilecki MW; Józefik B
    Psychiatr Pol; 2012; 46(2):201-12. PubMed ID: 23214391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of antidepressant treatment for bulimia nervosa.
    Walsh BT; Hadigan CM; Devlin MJ; Gladis M; Roose SP
    Am J Psychiatry; 1991 Sep; 148(9):1206-12. PubMed ID: 1882999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom fluctuation in eating disorders: correlates of diagnostic crossover.
    Tozzi F; Thornton LM; Klump KL; Fichter MM; Halmi KA; Kaplan AS; Strober M; Woodside DB; Crow S; Mitchell J; Rotondo A; Mauri M; Cassano G; Keel P; Plotnicov KH; Pollice C; Lilenfeld LR; Berrettini WH; Bulik CM; Kaye WH
    Am J Psychiatry; 2005 Apr; 162(4):732-40. PubMed ID: 15800146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group.
    Arch Gen Psychiatry; 1992 Feb; 49(2):139-47. PubMed ID: 1550466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change.
    Goldbloom DS; Olmsted MP
    Am J Psychiatry; 1993 May; 150(5):770-4. PubMed ID: 8480824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.